i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Research news

Tweets

Cancer

Advanced cancer, Bioinformatics, Biomarkers, Cancer progression, Carcinomas, Drug resistance, Novel anti-cancer agents, Proteomics, Signalling pathways

Molecular & Regenerative Medicine

Advanced Digital Primary Health Care, Health Services Research, Primary Health Care

Emeritus

Adjuvant therapy in breast cancer, Breast cancer, Breast cancer prevention, Breast cancer surgery, Clinical trials, Early-stage breast cancer, Surgical oncology

Clinical Epidemiology

Cardiology, Cardiovascular disease prevention, Clinical trials, E-cigarettes, Epidemiology, Meta-analysis, Smoking cessation, Systematic review

Clinical Epidemiology

Clinical trials, Post-thrombotic syndrome, Prevention, Pulmonary embolism, Treatment, Venous thromboembolism

Cancer

Apoptosis, Cell cycle control, Cell proliferation, Endoplasmic-reticulum stress, Interferon, mRNA translation, Protein phosphorylation, Signal transduction, Tumor suppressor p53, Virus infection, Virus-mediated oncogenesis

Clinical Epidemiology

Advanced cardiac imaging, Cardiac MRI, Cardiovascular diseases, Deep learning, Echocardiography, Epidemiology, Frailty, Geriatric cardiology, Machine learning, Sarcopenia

Molecular & Regenerative Medicine

Endothelin, Endothelium, Gamma/delta T lymphocytes, Genes, Immune mechanisms, Inflammation, Renin-angiotensin-aldosterone system, Single cell sequencing, T cells, Vascular remodeling

National Collaborations and Partnerships

LDI logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.